SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-294438
Filing Date
2023-12-13
Accepted
2023-12-13 17:06:53
Documents
14
Period of Report
2023-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d19807d8k.htm   iXBRL 8-K 40122
2 EX-10.1 d19807dex101.htm EX-10.1 341517
3 EX-10.2 d19807dex102.htm EX-10.2 108139
  Complete submission text file 0001193125-23-294438.txt   735369

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bttx-20231213.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bttx-20231213_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bttx-20231213_pre.xml EX-101.PRE 11261
8 EXTRACTED XBRL INSTANCE DOCUMENT d19807d8k_htm.xml XML 3378
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 231484835
SIC: 8000 Services-Health Services